Skip to main content

Advertisement

SpringerLink
Log in

Involvement of miR-30b in kynurenine-mediated lysyl oxidase expression

  • ORIGINAL ARTICLE
  • Published:
Journal of Physiology and Biochemistry Aims and scope Submit manuscript

Abstract

Microenvironment components profoundly influence the propensity of cancer metastasis through regulating key molecules controlling metastasis. Lysyl oxidase (LOX) contributes to extracellular matrix (ECM) remodeling, and finally promoting bone metastasis in breast cancer. Kynurenine (Kyn), a microenvironment component, is capable of regulating the biological behaviors of cancer cells, such as promoting node metastasis in vivo. However, it is still unclear whether Kyn controls the generation of LOX. In the current study, a significant increase of migration in the Kyn (30, 50, 100, 200, and 500 μM) group was detected compared with that in the control group in 95D cells in vitro. Subsequently, we demonstrated that 50 μM Kyn not only substantially upregulated the mRNA and secreted levels of LOX rather than cytoplasmic LOX, but also markedly reduced the level of miR-30b at the same time. Furthermore, the direct interaction between LOX mRNA and miR-30b was also confirmed by dual-luciferase assay system. Most importantly, not only was Kyn-induced increase of LOX mRNA significantly attenuated on miR-30b mimics treatment, but also Kyn-mediated the upregulation of the mRNA, and secreted levels of LOX were distinctly strengthened on miR-30b inhibitor treatment. These results suggest that miR-30b is involved in Kyn-mediated LOX expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Baker AM, Bird D, Lang G, Cox TR, Erler JT (2013) Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK. Oncogene 32:1863–1868

    Article  CAS  PubMed  Google Scholar 

  2. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Chen S, Li P, Yang R, Cheng R, Zhang F, Wang Y, Chen X, Sun Q, Zang W, Du Y, Zhao G, Zhang G (2015) MicroRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancer. Cancer Cell Int 15:85

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Chang CC, Zhang QY, Liu Z, Clynes RA, Suciu-Foca N, Vlad G (2012) Downregulation of inflammatory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(+) T suppressor cells. J Immunol 188:3042–3052

    Article  CAS  PubMed  Google Scholar 

  5. Cox TR, Rumney RM, Schoof EM, Perryman L, Høye AM, Agrawal A, Bird D, Latif NA, Forrest H, Evans HR, Huggins ID, Lang G, Linding R, Gartland A, Erler JT (2015) The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature 522:106–110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Crotti S, Piccoli M, Rizzolio F, Giordano A, Nitti D, Agostini M (2017) Extracellular matrix and colorectal Cancer: how surrounding microenvironment affects cancer cell behavior? J Cell Physiol 232:967–975

    Article  CAS  PubMed  Google Scholar 

  7. Duan Z, Duan Y, Lei H, Hu N, Shi J, Shen D, Wang X, Hu Y (2014) Attenuation of antigenic immunogenicity by kynurenine, a novel suppressive adjuvant. Hum Vacc Immunother 10:1295–1305

    Article  CAS  Google Scholar 

  8. Duan ZQ, Shi JD, Wu MN, Hu NZ, Hu YZ (2016) Influence of miR-30b regulating humoral immune response by genetic difference. Immunol Res 64:181–190

    Article  CAS  PubMed  Google Scholar 

  9. Erler JT, Bennewith KL, Nicolau M, Dornhöfer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ (2006) Lysyl oxidase is essential for hypoxiainduced metastasis. Nature 440:1222–1226

    Article  CAS  PubMed  Google Scholar 

  10. Farazi TA, Hoell JI, Morozov P, Tuschl T (2015) MicroRNAs in human cancer. Adv Exp Med Biol 774:1–20

    Google Scholar 

  11. Ferns DM, Kema IP, Buist MR, Nijman HW, Kenter GG, Jordanova ES (2015) Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival. Oncoimmunology 4:e981457

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Guo Y, Pischon N, Palamakumbura AH, Trackman PC (2007) Intracellular distribution of the lysyl oxidase propeptide in osteoblastic cells. Am J Phys Cell Phys 292:C2095–C2102

    Article  CAS  Google Scholar 

  13. Heyes MP, Saito K, Major EO, Mlistien S, Markey SP, Vickers JH (1993) A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain 116:1425–1450

    Article  PubMed  Google Scholar 

  14. Hoshi M, Ito H, Fujigaki H, Takemura M, Takahashi T, Tomita E, Ohyama M, Tanaka R, Saito K, Seishima M (2009) Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity. Leuk Res 33:39–45

    Article  CAS  PubMed  Google Scholar 

  15. Hou X, Du H, Quan X, Shi L, Zhang Q, Wu Y, Liu Y, Xiao J, Li Y, Lu L, Ai X, Zhan M, Yuan S, Sun L (2018) Silibinin inhibits NSCLC metastasis by targeting the EGFR/LOX pathway. Front Pharmacol 9:21

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ichikawa T, Sato F, Terasawa K, Tsuchiya S, Toi M, Tsujimoto G, Shimizu K (2012) Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells. PLoS One 7:e31422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769–773

    Article  CAS  PubMed  Google Scholar 

  18. Li SY, Yan JQ, Song Z, Liu YF, Song MJ, Qin JW, Yang ZM, Liang XH (2017) Molecular characterization of lysyl oxidase-mediated extracellular matrix remodeling during mouse decidualization. FEBS Lett 591:1394–1407

    Article  CAS  PubMed  Google Scholar 

  19. Mellor AL, Munn DH (1999) Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 20:469–473

    Article  CAS  PubMed  Google Scholar 

  20. Nishioka T, Eustace A, West C (2012) Lysyl oxidase: from basic science to future cancer treatment. Cell Struct Funct 37:75–80

    Article  CAS  PubMed  Google Scholar 

  21. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, Jugold M, Guillemin GJ, Miller CL, Lutz C, Radlwimmer B, Lehmann I, von Deimling A, Wick W, Platten M (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478:197–203

    Article  CAS  PubMed  Google Scholar 

  22. Palamakumbura AH, Vora SR, Nugent MA, Kirsch KH, Sonenshein GE, Trackman PC (2009) Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling. Oncogene 28:3390–3400

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Rogers S, de Souza AR, Zago M, Iu M, Guerrina N, Gomez A, Matthews J, Baglole CJ (2017) Aryl hydrocarbon receptor (AhR)-dependent regulation of pulmonary miRNA by chronic cigarette smoke exposure. Sci Rep 7:40539

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Schapers RF, Pauwels RP, Havenith MG, Smeets AW, van den Brandt PA, Bosman FT (1990) Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder. Cancer 66:2583–2588

    Article  CAS  PubMed  Google Scholar 

  25. Sun X, Zhao S, Li H, Chang H, Huang Z, Ding Z, Dong L, Chen J, Zang Y, Zhang J (2016) MicroRNA-30b suppresses epithelial-mesenchymal transition and metastasis of hepatoma cells. J Cell Physiol 232:625–634

    Article  CAS  PubMed  Google Scholar 

  26. Tian SB, Yu JC, Liu YQ, Kang WM, Ma ZQ, Ye X, Yan C (2015) MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer. World J Gastroenterol 21:9337–9347

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Wang TH, Hsia SM, Shieh TM (2016) Lysyl oxidase and the tumor microenvironment. Int J Mol Sci 18(1).

  28. Watanabe Y, Fujiwara M, Yoshida R, Hayaishi O (1980) Stereospecificity of hepatic L-tryptophan 2,3-dioxygenase. Biochem J 189:393–405

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Yoshikawa T, Hara T, Tsurumi H, Goto N, Hoshi M, Kitagawa J, Kanemura N, Kasahara S, Ito H, Takemura M, Saito K, Seishima M, Takami T, Moriwaki H (2010) Serum concentration of L-kynurenine predicts the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP. Eur J Haematol 84:304–309

    Article  CAS  PubMed  Google Scholar 

  30. Zhao H, Xu Z, Qin H, Gao Z, Gao L (2014) MiR-30b regulates migration and invasion of human colorectal cancer via SIX1. Biochem J 460:117–125

    Article  CAS  PubMed  Google Scholar 

  31. Zhao Y, Min C, Vora SR, Trackman PC, Sonenshein GE, Kirsch KH (2009) The lysyl oxidase propeptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells. J Biol Chem 284:1385–1393

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Zhong K, Chen K, Han L, Li B (2014) MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18. BMC Cancer 14:703

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Zhu Y, Yao S, Chen L (2011) Cell surface signaling molecules in the control of immune responses: a tide model. Immunity 34:466–478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was supported by the Foundation of Shanxi Educational Committee (Grant No. 201802057), the Youth Research Fund of Shanxi Province (Grant No. 201601D021169), and the Youth Research Fund of Shanxi Medical University (Grant No. 02201518).

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shanxi Medical University, 56 South Xinjian Road, Taiyuan, 030001, Shanxi, People’s Republic of China

    Zhiqing Duan

  2. Shanxi Key Laboratory of Bone and Soft Tissue Injury Repair, Department of Orthopaedics, The Second Hospital of Shanxi Medical University, 382 Wuyi Road, Taiyuan, 030001, Shanxi, People’s Republic of China

    Lu Li & Yan Li

Authors
  1. Zhiqing Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lu Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhiqing Duan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOC 136 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Duan, Z., Li, L. & Li, Y. Involvement of miR-30b in kynurenine-mediated lysyl oxidase expression. J Physiol Biochem 75, 135–142 (2019). https://doi.org/10.1007/s13105-019-00686-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13105-019-00686-4

Keywords

Search

Navigation